Filing
2nd Quarter - Report
Lobbying activity
1
Education about efforts to provide greater resiliency in the drug supply chain. FY 2027 National Defense Authorization Act (NDAA).
Education about efforts to provide greater resiliency in the drug supply chain. FY 2027 National Defense Authorization Act (NDAA).